Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Blood|November 22, 2014
Fc-optimized antibodies quickly pull the triggerChristian Kellner, Matthias PeippGeburtshilfe Und Frauenheilkunde|June 25, 2021
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast CancerDiana Lüftner, Matthias PeippOncoimmunology|July 30, 2013
Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotypeChristian Kellner, Martin Gramatzki, Matthias PeippMabs|January 14, 2010
Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodiesMatthias Peipp, Michael Dechant, Thomas ValeriusCurrent Opinion in Immunology|July 1, 2008
Effector mechanisms of therapeutic antibodies against ErbB receptorsMatthias Peipp, Michael Dechant, Thomas ValeriusMethods in Molecular Biology (Clifton, N.J.)|July 5, 2023
Identification of New Antibodies Targeting Tumor Cell Surface Antigens by Phage DisplaySteffen Krohn, Matthias Peipp, Katja KlauszMethods (San Diego, Calif.)|July 16, 2013
Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functionsChristian Kellner, Stefanie Derer, Thomas Valerius, et al.Best Practice & Research. Clinical Haematology|June 11, 2011
Molecular engineering to improve antibodies' anti-lymphoma activityMatthias Peipp, Jan G J van de Winkel, Thomas ValeriusMethods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fc engineering: design, expression, and functional characterization of antibody variants with improved effector functionStefanie Derer, Christian Kellner, Sven Berger, et al.Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer TherapyChristian Kellner, Anna Otte, Elisa Cappuzzello, et al.Pageof 13